Cargando…
Healthy Volunteers for Clinical Trials in Resource-Poor Settings: National Registries Can Address Ethical and Safety Concerns
Healthy volunteers (HVs) who participate in clinical trials are a vulnerable group that deserves specific protection. We assessed the number and types of studies that involve HVs around the world and outline the methodological barriers to their analysis. We found that tens of thousands of HVs are in...
Autor principal: | BOMPART, FRANCOIS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317110/ http://dx.doi.org/10.1017/S0963180118000476 |
Ejemplares similares
-
Continued Access to Investigational Medicinal Products for Clinical Trial Participants—An Industry Approach
por: KELMAN, ARIELLA, et al.
Publicado: (2019) -
Involving Patients in Research? Responsible Research and Innovation in Small- and Medium-Sized European Health Care Enterprises
por: IORDANOU, KALYPSO
Publicado: (2019) -
Working Together to Make the World a Healthier Place: Desiderata for the Pharmaceutical Industry
por: LEISINGER, KLAUS M., et al.
Publicado: (2019) -
Ethical rationale for better coordination of clinical research on COVID-19
por: Bompart, Francois
Publicado: (2020) -
Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
por: Fisher, Jill A, et al.
Publicado: (2021)